All News about Inventiva S.A. ADRVia Benzinga
Inventiva To Change Clinical Development of Its Lead NASH Candidate
January 05, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|